Laurie H. Sehn
0000-0003-1860-9765
Publication & Citation Trends
Publications
0 total
Quantitative PET/CT measures from consensus and union of threshold and AI-based segmentation for outcome prediction in limited-stage follicular lymphoma
Cited by 0
Semantic Scholar
Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology
Cited by 1
Semantic Scholar
Retreatment with R-CHOP–like therapy in patients with late relapse of diffuse large B-cell lymphoma
Cited by 0
Semantic Scholar
Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2.
Cited by 6
Semantic Scholar
Maximum disease diameter is associated with outcomes in stage II follicular lymphoma treated with radiation therapy alone OA
Cited by 1
Semantic Scholar
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma. OA
Cited by 4
Semantic Scholar
CNS Relapse in High-Grade B-cell Lymphoma with MYC and BCL2 Rearrangements and Dark-Zone Signature-Expressing DLBCL. OA
Cited by 9
Semantic Scholar
Motive and Opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements-an LLMPP study.
Cited by 21
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(555)
Chronic Lymphocytic Leukemia Research
(238)
CAR-T cell therapy research
(114)
Viral-associated cancers and disorders
(112)
CNS Lymphoma Diagnosis and Treatment
(103)
Affiliations
New School
Ontario Institute for Cancer Research
Universitat Autònoma de Barcelona
University of Maryland, Baltimore
Brigham and Women's Hospital